2004
DOI: 10.1097/01.ccm.0000114575.08269.f6
|View full text |Cite
|
Sign up to set email alerts
|

Novel endothelin receptor antagonist attenuates endotoxin-induced lung injury in sheep

Abstract: In an ovine model of endotoxin-induced lung injury, tezosentan ameliorates pulmonary hypertension, lung edema, cardiac dysfunction, and arterial hypoxemia. Tezosentan counteracts the hemodynamic effects of endothelin-1 in a dose-dependent manner.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

12
54
1
1

Year Published

2007
2007
2018
2018

Publication Types

Select...
10

Relationship

0
10

Authors

Journals

citations
Cited by 46 publications
(68 citation statements)
references
References 34 publications
12
54
1
1
Order By: Relevance
“…It is well established that infusion of LPS stimulates release of inflammatory mediators such as TNF-α, IL-8, and ET-1 (3,21,39). Similarly, ET-1 stimulates monocytes and macrophages to release TNF-α and IL-8 (11,12), and enhanced plasma concentrations of TNF-α, IL-8, and ET-1 were found after 4 h in endotoxemic subjects (19). Finally, increases in ET-1 and TNF-α were found to be consistent in a study that used endothelin receptor antagonist bosentan (41).…”
Section: Animals and Treatmentsmentioning
confidence: 96%
“…It is well established that infusion of LPS stimulates release of inflammatory mediators such as TNF-α, IL-8, and ET-1 (3,21,39). Similarly, ET-1 stimulates monocytes and macrophages to release TNF-α and IL-8 (11,12), and enhanced plasma concentrations of TNF-α, IL-8, and ET-1 were found after 4 h in endotoxemic subjects (19). Finally, increases in ET-1 and TNF-α were found to be consistent in a study that used endothelin receptor antagonist bosentan (41).…”
Section: Animals and Treatmentsmentioning
confidence: 96%
“…We found an early significant decrease in Edn1 lung expression following kidney IRI, and therefore found it to be an ideal candidate gene to validate our ability to accurately measure genes whose expression is deactivated following treatment. In addition, Edn-1 is a potent vasoconstrictor and its expression is associated with pulmonary endothelial injury and microvascular leak (15,21). The deactivation of gene expression at 6 h may represent a response to an increase in early protein abundance or activity, and given that it is also the gene with most links to "acute lung injury" term in the PubMed database, makes Edn1 an attractive candidate gene to be investigated as a potential mediator of AKI-induced ALI in future studies.…”
Section: Discussionmentioning
confidence: 99%
“…Studies have shown that LPS stimulates the synthesis of ET-1 both in vivo and in vitro (Ohta et al 1990;Forni et al 2005;Zaedi et al 2006). Furthermore, the use of a nonselective endothelin receptor antagonist, tezosentan, has been shown to limit various hemodynamic abnormalities associated with endotoxemia, including pulmonary edema (Kuklin et al 2004;Rossi et al 2004).…”
Section: Discussionmentioning
confidence: 99%